Utilizing left atrial strain to identify patients at risk for atrial fibrillation on ibrutinib.

Arushi SinghNadia El HangoucheKatherine McGeeFei-Fei GongRobert LentzJoseph FeinglassNausheen Akhter

Published in: Echocardiography (Mount Kisco, N.Y.) (2020)

Age, ibrutinib dose, E/e', and PALS on pre-treatment echocardiogram were significantly associated with development of IRAF. On multivariate regression analyses, age, PALS, and PACS remained significantly associated with IRAF. Impaired LA mechanics add to the assessment of patients at risk for IRAF.

Keyphrases

left atrial
atrial fibrillation
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
heart failure
left ventricular
acute coronary syndrome
oral anticoagulants